Vifor Pharma (United States)
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
53%
Total
Publications
185
Total Open
Publications
98
Total
Citations
4.5K
Open Access
Percentage
53%
Total
Publications
185
Total Open
Publications
98
Total
Citations
4.5K
Breakdown
Publisher Open
17%
Both
27%
Other Platform Open
9%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
33
Hybrid 37%
30
No Guarantees 23%
19
Other Platform Open
Domain 86%
57
Institution 17%
11
Preprint 11%
7
Other Internet 9%
6
Public 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 57 |
Europe PMC | Domain | 23 |
Research Square | Preprint | 7 |
University College London - UCL Discovery | Institution | 6 |
University of Michigan - Deep Blue | Institution | 4 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 3 |
Semantic Scholar | Public | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART | Other Internet | 2 |
University of Zurich - Zurich Open Repository and Archive | Institution | 1 |